ArticleEuropean urology2021

Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.

Christopher J Sweeney et al.PubMed ↗Publisher ↗

No numbers read from the abstract.